跳至主要内容
临床试验/NCT04196023
NCT04196023已完成不适用

Ca:Mg Ratio and Cognitive Function in the Personalized Prevention of Colorectal Cancer Trial

Vanderbilt University Medical Center0 个研究点目标入组 129 人开始时间: 2012年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
129
主要终点
Overall Score Changes From Baseline by Magnesium Treatment vs. Placebo

研究概览

简要总结

Between 2000 and 2015, mortality due to Alzheimer's disease (AD) increased by 123%. No drugs have yet been approved to stop or slow the progression of AD. A delay of five years in the expression of AD would reduce the incidence rate by half. Thus, it is critical to develop novel prevention strategies to delay the onset of this common disease.

As an ancillary study conducted within a precision-based randomized trial (R01CA149633; PI, Dai & Yu]"), the investigators reduced Ca:Mg ratios to 2.3 through 3-month personalized Mg supplementation among those who consumed high Ca:Mg ratio diet, but otherwise in good general health. The investigators test the hypothesis that actively reducing the Ca:Mg ratio among those aged >65 years who consume high Ca:Mg ratio diets improves cognitive function compared to the placebo arm. The investigators further conduct molecular epidemiologic studies to understand the molecular mechanisms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants from our parent study (Personalized Prevention of Colorectal Cancer Trial, NCT#01105169, IRB#100106);
  • Participants who completed the MoCA

排除标准

  • Participants did not provide their blood samples in the parent study.

结局指标

主要结局

Overall Score Changes From Baseline by Magnesium Treatment vs. Placebo

时间窗: 12 weeks

Montreal Cognitive Assessment (MoCA) Scoring: The test consists of 30 items, and each item is worth one point, resulting in a maximum score of 30. A higher score indicates better cognitive functioning. The changes of MoCA score=Score at 12 weeks minus Score at baseline.

Overall Score Changes From Baseline by Magnesium Treatment vs. Placebo (Aged ≤65 Years Old)

时间窗: 12 weeks

Montreal Cognitive Assessment (MoCA) Scoring: The test consists of 30 items, and each item is worth one point, resulting in a maximum score of 30. A higher score indicates better cognitive functioning. The changes of MoCA score=Score at 12 weeks minus Score at baseline.

Overall Score Changes From Baseline by Magnesium Treatment vs. Placebo (Aged >65 Years Old)

时间窗: 12 weeks

Montreal Cognitive Assessment (MoCA) Scoring: The test consists of 30 items, and each item is worth one point, resulting in a maximum score of 30. A higher score indicates better cognitive functioning. The changes of MoCA score=Score at 12 weeks minus Score at baseline.

Changes From Baseline of 5-mC Methylation (CpG Sites) in Apolipoprotein E (APOE) by Magnesium Treatment vs. Placebo

时间窗: 12 weeks

5-mC methylation (CpG sites) in Apolipoprotein E (APOE) were measure by TET-assisted bisulfite (TAB)-Array. 5-mC methylation changes=value at 12 weeks minus value at baseline.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Qi Dai

Professor of Medicine

Vanderbilt University Medical Center

相似试验

Ca:Mg Ratio and Cognitive Function | 临床试验